The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The 50-page lawsuit claims the actions of the labs has violated state law, intentionally interfered with MCR’s business ...
A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.
Elshoma McCoy, 49, of 176 Waverly St., Framingham, is charged with illegal possession of a firearm; illegal possession of a ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that ...
Biogen and Sage co-developed Zurzuvae, which was approved by the FDA for PPD in August 2023. Sage has experienced several setbacks since this approval. Zurzuvae did not win approval as a treatment ...
Mayor Charlie Sisitsky delivered his State of the City address on Monday. It was the mayor's fourth time delivering the ...
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
Dogs can also be affected by certain pet food, but the Food and Drug Administration (FDA) has stated that their ... since 2022 - there have been none in Massachusetts," DPH spokesperson Kathleen ...